| Literature DB >> 34590761 |
Maríllya Morais da Silva1, André Silva Lira de Lucena1, Sergio de Sá Leitão Paiva Júnior2, Vanessa Mylenna Florêncio De Carvalho1, Priscilla Stela Santana de Oliveira1, Michelle Melgarejo da Rosa1, Moacyr Jesus Barreto de Melo Rego1, Maira Galdino da Rocha Pitta1, Michelly Cristiny Pereira1.
Abstract
Coronavirus disease 2019 (Covid-19) is an emerging novel respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that rapidly spread worldwide. In addition to lung injury, Covid-19 patients may develop extrapulmonary symptoms, including cardiac, liver, kidney, digestive tract, and neurological injuries. Angiotensin converting enzyme 2 is the major receptor for the entry of SARS-CoV-2 into host cells. The specific mechanisms that lead to cell death in different tissues during infection by SARS-CoV-2 remains unknown. Based on data of the previous human coronavirus SARS-CoV together with information about SARS-CoV-2, this review provides a summary of the mechanisms involved in cell death, including apoptosis, autophagy, and necrosis, provoked by severe acute respiratory syndrome coronavirus.Entities:
Keywords: Sars-CoV-2; cell death; pathways
Mesh:
Year: 2021 PMID: 34590761 PMCID: PMC8646768 DOI: 10.1002/rmv.2292
Source DB: PubMed Journal: Rev Med Virol ISSN: 1052-9276 Impact factor: 11.043
FIGURE 1Illustration of the genome of severe acute respiratory syndrome coronavirus (SARS‐CoV) and SARS‐CoV‐2 showing the location of structural proteins, open reading frames (orf1a and orf1ab), accessory proteins which them are known to trigger different forms of cell death. *ORF3b and ORF8b is only present in SARS‐CoV. **ORF10 is only present in SARS‐CoV‐2
FIGURE 2Summary of the mechanisms that lead to apoptosis triggered by the structural and accessory proteins of severe acute respiratory syndrome coronavirus (SARS‐CoV)
FIGURE 3Mechanisms associated with autophagy triggered by coronaviruses
FIGURE 4(a)–Pyroptosis triggered by the 3a protein of SARS‐CoV; (b)—3a protein of SARS‐CoV leads to necroptotic cell death by the ability of the SARS 3a protein to oligomerize and insert into membranes
Cell death and CoVs
| Autor | Ano | CoV | CellLine | Tissue | Cell death | Reference |
|---|---|---|---|---|---|---|
| Surjit, Milan et al. | 2004 | SARS‐CoV | COS‐1, HuH7 | Kidney | Apoptosis |
|
| Tan, Yee‐Joo et al. | 2004 | SARS‐CoV | HEK293T, HeLa, A549, HepG2, Vero E6, COS‐7 | Kidney, cervix, lung, liver, | Apoptosis |
|
| Ren, Lili et al. | 2005 | SARS‐CoV | Vero | Kidney | Apoptosis |
|
| Law, Patrick T W et al. | 2005 | SARS‐CoV | Vero E6 | Kidney | Apoptosis |
|
| Kopecky‐Bromberg, Sarah A et al. | 2006 | SARS‐CoV | HEK293T, A549, and HeLa | Human embryonic kidney, lungs, cervix | Apoptosis |
|
| Khan, Sehaam et al. | 2006 | SARS‐CoV | Vero E6 | Kidney | Apoptosis and neccrosis |
|
| Chan, Chak‐Ming et al. | 2007 | SARS‐CoV | HEK293T, TransgenicDrosophila | Kidney | Apoptosis |
|
| Chen, Chia‐Yen et al. | 2007 | SARS‐CoV | VeroE6, HEK 293T, and HuH‐7 | Kidney human embryonic kidney | Apoptosis |
|
| Zhang, Lu et al. | 2007 | SARS‐CoV | COS‐1 | Kidney | Apoptosis |
|
| Tan, Ying‐Xim et al. | 2007 | SARS‐CoV | VeroE6, HEK293T | Kidney | Apoptosis |
|
| Chan, E et al. | 2008 | SARS‐CoV | Vero E6 e 3a TransgenicDrosophilamodel | Kidney | Apoptosis |
|
| Padhan, Kartika et al. | 2008 | SARS‐CoV | Huh7 | Kidney | Apoptosis |
|
| Ye, Zhongde et al. | 2008 | SARS‐CoV | Vero E6, COS‐7 cells and HEK293T cells | Kidney and human embryonic kidney | Apoptosis |
|
| Minakshi, Rinki et al. | 2009 | SARS‐CoV | COS‐1, Vero, Huh7 | Kidney | Apoptosis |
|
| Freundt, Eric C et al. | 2009 | SARS‐CoV | Vero cells | Kidney | Apoptosis |
|
| Ye et al. | 2010 | SARS‐CoV | Vero E6 and COS‐7 cells | Kidney | Apoptosis |
|
| Sharma, Kulbhushan et al. | 2011 | SARS‐CoV | Vero cells | Kidney | Apoptosis |
|
| Tsoi, Ho et al. | 2014 | SARS‐CoV | HEK293FT | Kidney | Apoptosis |
|
| Nieto‐Torres, Jose L et al. | 2014 | SARS‐CoV | Vero E6, BHK‐21 cells | Kidney | Pyroptosis |
|
| Chu, Hin et al. | 2016 | MERS‐CoV | Peripheral blood mononuclear cells, Tcells and tonsil and spleen‐dissociated cells | Blood | Apoptosis |
|
| Yeung, Man‐lung et al. | 2016 | MERS‐CoV | Calu‐3 and normal human mesangial cells | Lungs, kidney | Apoptosis |
|
| Yue, Yuan et al. |
| SARS‐CoV | HeLa, HEK 293T, A549, Thp‐1 | Cervix, kidney, lung, peripheral blood | Necrosis |
|
| Chen, I‐Yin et al. | 2019 | SARS‐CoV | BMMs, HEK293FT, HeLa, HT‐1080 | Kidney, Cervix, connective tissue | Pyroptosis |
|
| Shi, Chong‐Shan et al. | 2019 | SARS‐ CoV | THP‐1, HEK293, A549, HeLa | Peripheral blood, kidney, lung, cervix | Autophagy |
|
| Jiang, Yuting et al. | 2019 | MERS‐CoV | Human monocytic cells (THP‐1) | Blood | Pyroptosis |
|
| Carmona‐Gutierrez, Didac et al. | 2020 | MERS‐CoV,SARS‐CoV | ‐ | ‐ | Autophagy |
|
| Li, Shaohua et al. | 2020 | SARS‐CoV‐2 | ‐ | ‐ | Pyroptosis |
|
| Li, Shufen et al. | 2020 | SARS‐CoV‐2 | Calu‐3, Vero, Vero E6, THP‐1 | Lung | ApoptosisNecroptosis |
|
| Shojaei, Shahla et al. | 2020 | SARS‐CoV‐2 | ‐ | ‐ | Autophagy |
|
| Bellesi, Silvia et al. | 2020 | SARS‐CoV‐2 | Peripheral blood T Lympocytes | Blood | Apoptosis |
|
| Ren, Yujie et al. | 2020 | SARS‐CoV‐2 | VeroE6, HEK293T and HepG2 | Kidney, lung | Apoptosis |
|
| Rodrigues, Tamara S et al. | 2021 | SARS‐CoV‐2 | Peripheral blood mononuclear cells | Blood | Pyroptosis |
|
| Ferreira, André C et al. | 2021 | SARS‐CoV‐2 | Vero E6, human primary monocytes | Kidney, blood | Pyroptosis |
|
Abbreviations: CoVs, coronaviruses; MERS‐CoV, Middle East respiratory syndrome coronavirus; SARS‐CoV, severe acute respiratory syndrome coronavirus.
FIGURE 5Biomolecular interaction network with genes found by text‐mining analysis
FIGURE 6Heat map enrichment of death‐related biological process and genes of Sars‐CoV (negative log10 of adjusted p‐value)